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AbstrACt
Introduction Chronic subdural haematoma (cSDH) 
tends to occur in older patients, often with significant 
comorbidity. The incidence and effect of medical 
complications as well as the impact of intraoperative 
management strategies are now attracting increasing 
interest.
Objectives We used electronic health record data to 
study the profile of in- hospital morbidity and examine 
associations between various intraoperative events and 
postoperative stay.
Design, setting and participants Single- centre, 
retrospective cohort of 530 cases of cSDH (2014–2019) 
surgically evacuated under general anaesthesia at a 
neurosciences centre in Cambridge, UK.
Methods and outcome definition Complications 
were defined using a modified Electronic Postoperative 
Morbidity Score. Association between complications and 
intraoperative care (time with mean arterial pressure 
<80 mm Hg, time outside of end- tidal carbon dioxide 
(ETCO2) range of 3–5 kPa, maintenance anaesthetic, 
operative time and opioid dose) on postoperative stay was 
assessed using Cox regression.
results 53 (10%) patients suffered myocardial 
injury, while 24 (4.5%) suffered acute renal injury. 
On postoperative day 3 (D3), 280 (58% of remaining) 
inpatients suffered at least 1 complication. D7 rate 
was comparable (57%). Operative time was the only 
intraoperative event associated with postoperative stay 
(HR for discharge: 0.97 (95% CI: 0.95 to 0.99)). On 
multivariable analysis, postoperative complications (0.61 
(0.55 to 0.68)), anticoagulation (0.45 (0.37 to 0.54)) and 
cognitive impairment (0.71 (0.58 to 0.87)) were associated 
with time to discharge.
Conclusions There is a high postoperative morbidity 
burden in this cohort, which was associated with 
postoperative stay. We found no evidence of an 
association between intraoperative events and 
postoperative stay.
IntrODuCtIOn
Chronic subdural haematoma (cSDH) is a 
common neurosurgical pathology of encap-
sulated blood products beneath the dural 
membrane, driven by trauma and inflam-
mation.1 Although cSDH can be managed 
conservatively, surgical evacuation is favoured 
in the presence of neurological deficit. cSDH 
is predominantly a ‘disease of the elderly’. It is 
also associated with frailty and comorbidity.2–5 
Increased mortality at 1 year among individ-
uals with a cSDH has led some to consider it 
a ‘sentinel health event’.6 In these respects, 
there is a clear analogy with patients suffering 
a fracture of the neck of femur (NOF), a 
group whose outcomes have recently been 
improved by concerted efforts into the 
measurement, integration and improvement 
of holistic perioperative care.7 8 However, with 
cSDH, although a similarly effective surgical 
intervention exists, there has, as yet, been 
no demonstration of a systematic improve-
ment in patient outcomes through analogous 
process changes.
strengths and limitations of this study
 ► First use of electronic health data to chart the time 
course of in- hospital complications in a neurosur-
gical cohort.
 ► Use of multiple imputation to maximise power with 
clear comparison to complete case analysis for 
comparison.
 ► Methodological approaches are scalable to other 
surgical and in- patient cohorts.
 ► Main results limited by being a single- centre, retro-
spective study, and thus lack external validity.
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To date, the impact of non- neurological morbidity in 
patients with cSDH has received little attention.9 The 
reasons for this are likely multifactorial, but crucially there 
are significant challenges in adequately capturing patient 
morbidity using standard methodological approaches, 
which typically rely on cross- sectional assessment at set 
time points.10 However, there is some evidence to suggest 
that non- neurological morbidity may be a significant 
problem. In a nationwide audit of UK cSDH manage-
ment, 110 (14%) of 787 surgically treated patients 
suffered a complication, of which pneumonia was the 
most common.11 The prevalence of such complications 
appears to increase with age.12 13 The experience from 
parallel surgical fields would suggest this morbidity has 
implications for both patient outcomes, and the delivery 
of cost- effective healthcare.14 This highlights a need for a 
more detailed investigation into the relationship between 
perioperative morbidity and outcome in cSDH. An under-
standing of the impact of all stages of the perioperative 
pathway on patient outcome is vital if potential clinical 
and service benefits from tailored process change, analo-
gous to those in the NOF population, are to be realised.8
Surgery for cSDH is commonly performed under 
general anaesthesia (GA). Heterogeneity in anaesthetic 
practice has the potential to introduce variation in post-
operative outcome, yet the impact of intraoperative events 
on outcome has received little attention in cSDH. Phys-
iological changes, such as hypotension, can be a direct 
pharmacodynamic consequence of GA. Importantly, even 
brief periods below a mean arterial pressure (MAP) of 
80 mm Hg are associated with end- organ damage,15 and 
it is reasonable to assume that the cSDH population may 
be particularly vulnerable. Furthermore, arterial carbon 
dioxide tension (PaCO2) is no longer under homeostatic 
control during mechanical ventilation, which may have 
important implications for cerebral blood flow (CBF) 
and intracranial pressure (ICP).16 In cSDH, changes in 
CBF correlate with clinical symptoms.17 GA choice may 
also have postoperative effects. Opioids have numerous 
side effects that occur with increasing frequency in the 
elderly.18 The varied pharmacodynamic effects of anaes-
thetic agents have the potential to differentially impact 
on both ICP and CBF,19 with intravenous anaesthesia 
associated with lower rates of certain complications such 
as nausea and vomiting.20 However, a recent systematic 
review (of low quality evidence) failed to demonstrate 
a difference in delirium rate or length of stay (LOS) 
between patients receiving a volatile or intravenous 
anaesthetic.21
The advent of integrated electronic health records 
(EHR) allows the capture of complex events, such as intra-
operative physiology, and to comprehensive measure-
ment of in- patient morbidity across the entirety of an 
admission. New scoring systems are required to generate 
computable phenotypes from such complex, routinely 
collected data.22 One such score, an electronic variant of 
the widely used Postoperative Morbidity Score (POMS),10 
has equivalent discriminative performance in identifying 
discharge complexity or prolonged LOS in a heteroge-
neous population of elderly surgical patients.22 LOS is 
often critiqued as an outcome measure in improvement 
efforts due to the impact of non- clinical events.23 The 
complex relationship between clinical and non- clinical 
events in determining LOS is likely to vary between 
patients with differing disease processes. Regardless, its 
utility from the perspective of hospital bed occupancy is 
inarguable, with mounting health service pressures bed 
utilisation and patient throughput with minimal accrued 
morbidity is of crucial importance.
The aim of this study was to use routinely collected 
EHR data to examine, for the first time, the impact of 
intraoperative events and medical complications on post-
operative length of neurosurgical centre stay in patients 
undergoing surgery for cSDH.
MethODs
Cohort selection
This was a single- centre, retrospective evaluation of surgi-
cally treated cSDH at Cambridge University Hospitals 
NHS Foundation Trust (CUH) between 26 October 2014 
and 5 January 2019. CUH offers neurosurgical and trauma 
services to a population of approximately 5.8 million in 
the East of England (online supplementary figure S1).24 
Eight hundred and nine cases of cSDH were identified 
from the centre’s neurosurgical referrals database and 
operation log, coded contemporaneously by neurosur-
geons. After excluding missing records, duplicates and 
incorrect procedures, 530 patients were included in this 
retrospective cohort (online supplementary figure S2). 
The majority of patients (491, 92.5%) were transferred 
from other hospitals (n=14). Anonymised data for each 
case were extracted from the CUH EHR (Epic Systems 
Corporation, Verona, Wisconsin, USA) by the centre’s 
clinical informatics team.
Patient and public involvement statement
Due to the retrospective and evaluative nature of the 
project, no formal patient and public involvement work 
was undertaken.
Local surgical practice
Local practice is relatively standardised and comparable 
to the previously published literature.25 Procedures are 
predominantly performed under GA via two burr holes 
with subsequent irrigation and usage of a subdural drain 
on free drainage. The drain is removed after 48 hours with 
patients referred back to their local hospital at this point 
if required. Standard postoperative care is performed 
on a designated neurosurgical ward. Physiological obser-
vations are measured at a frequency dependent on the 
patients calculated ‘Early Warning Score’ in line with UK 
national guidance26 and at least two times within a 24- hour 
period for all inpatients. Mini- craniotomy is reserved for 
recurrence or complex collections. Due to the use of 
standard Classification of Interventions and procedure 
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Table 1 Definitions of the adapted Electronic Postoperative Morbidity Score (ePOMS) used for daily assessment of 
complications in a retrospective cohort of operated chronic subdural haematoma
Domain Diagnostic criteria Notes




Neurological Need for 1:1 nursing observation
Motor/Verbal Score worse than referral
Focal neurology
Surrogate for hyperactive delirium
Documented mismatch between left/right sided arm/leg 
strength at any stage
Renal Rise in creatinine to ≥1.5× baseline Last recorded creatinine prior to surgery
GI Administered antiemetic Defined by the following WHO ATC codes: a04*, a03fa01, 
r06ae03, n05ad08
Pain Need for intravenous opioids or local 
anaesthetic infusion on a given day
Drugs identified by following WHO ATC codes: n02aa01, 
n02ab03, n01bb01
Recurrence† Reoperation ePOMS originally identifies severe wound infection by need 
for further surgery. In this context reoperation for the same 
procedure is being used to identify reaccumulation of cSDH
Infection Temperature ≥38°C
Receiving antibiotics on a given day
Antibiotics defined by following WHO ATC codes: j01‡
Haematological Transfused with blood product Including red cells, platelets, FFP, cryoprecipitate
If multiple potential criteria are listed then an individual is positive in that domain if any of these are met.
*Indicates additional criterion included in this variant of ePOMS from those previously published.
†In the original ePOMS this would correspond to the wound category.
‡Indicates that all drugs below this level of ATC code were included. A dictionary of relevant ATC codes is available in the online 
supplementary material.
FFP, fresh frozen plasma; GCS, Glasgow Coma Scale; GI, gastrointestinal; HR, heart rate; SBP, systolic blood pressure; WHO ATC, World 
Health Organization anatomical therapeutic chemical classification.
(OPCS) codes for all forms of subdural drainage, specific 
surgical approach was unable to be resolved.
Covariate definitions
Perioperative medical complications
A variant of the electronic POMS (ePOMS)22 was used 
to determine the presence of morbidity across nine 
distinct domains, following key organ systems (respira-
tory, cardiovascular, neurological, renal, haematolog-
ical, gastrointestinal, infectious, reoperation/wound and 
pain) (table 1). Recognising that ePOMS had not previ-
ously been employed in a neurosurgical population, the 
score was modified to capture a greater number of dimen-
sions of neurological morbidity. These included a deteri-
oration in motor or verbal components of the Glasgow 
Coma Scale (GCS) (from admission), and the presence 
of asymmetric motor power. Therefore, the total score for 
an individual on any given day ranged between 0 and 11. 
Electronic observation, drug and laboratory result charts 
were extracted from the EHR and the daily ePOMS gener-
ated for each patient. Physiological criteria (eg, heart 
rate) were fulfilled if two or more instances occurred on 
a given day compared with a single event for investigation 
and drug- based criteria.
Intraoperative covariates
Automatically recorded physiological measurements 
(blood pressure and heart rate) and inspired/expired gas 
measurements were extracted from the EHR at minute 
resolution throughout GA. Blood pressure was measured 
both non- invasively (typically at a frequency of more than 
every 5 min27) and, for a subset of patients, invasively 
from an arterial catheter. All MAP values were combined 
and linearly interpolated. Total time (in minutes) spent 
below a threshold of 80 mm Hg15 was calculated. In an 
effort to reduce artefact, values of 0 or >200 mm Hg were 
excluded. Maintenance anaesthetic was deemed inha-
lational if there were non- zero values of an inhalational 
anaesthetic agent. Text labels of manually recorded drug 
administrations were converted using a lookup table 
matching drugs to their corresponding WHO anatomical 
therapeutic classification (WHO- ATC) code.28 All admin-
istrations of a drug with a code of N02A (opioid class) 
were extracted along with their dose. All opioid admin-
istrations were expressed as fentanyl equivalents using 
published conversions29 as this is the most commonly 
used opioid in local neuroanaesthetic practice. Brain 
injury guidelines suggest that ventilation is adjusted to 
keep the level of carbon dioxide measured in arterial 
blood (PaCO2) less than 6 and above 3.5 kPa.
30 As end 
tidal values underestimate the true arterial gas tension by 
between 0.5 and 1 kPa, time above an end- tidal carbon 
dioxide (ETCO2) of 5 kPa and time below an ETCO2 of 
3 kPa was calculated to give a total time outside of optimal 
CO2 range.
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Other covariates
To control for residual confounding, key admission 
characteristics were also extracted from the EHR and 
referral database. These included: age, sex, American 
Society of Anesthesiologists (ASA) Score, Modified 
Rankin Scale (mRS), admission location (direct or from 
a referring hospital), baseline neurological status (GCS 
15 yes/no and Motor Score 6 yes/no), admission creat-
inine and key comorbidities. Preoperative deterioration 
(defined as a worsening ePOMS between admission and 
time of surgery) and length of wait for surgery were also 
controlled for. Cognitive state on admission was defined 
using an Admission Screening Questionnaire that ascer-
tains the presence of temporary or permanent cognitive 
impairment. This was collapsed into a binary definition of 
‘any’ cognitive impairment versus none.
As the majority of patients referred for surgery had no 
previous admission on record, the baseline list of comor-
bidities was frequently incomplete. Comorbidities were 
inferred from admission medications using the ‘Rx- Risk’ 
Score, which uses WHO- ATC codes to determine the 
presence of specific comorbidities.31 This approach was 
chosen over discharge clinical coding to avoid potential 
reverse causation (eg, in- hospital myocardial infarction 
(MI) being wrongly interpreted as a pre- existing history 
of MI). Preadmission anticoagulant/antiplatelet use, 
airway disease, heart failure or cardiovascular disease was 
determined using medication records reconciled in the 
first 24 hours of an individual’s admission. Full codes used 
to determine comorbidity are shown in online supple-
mentary table S1.
statistical techniques
All analyses were performed in R (V.3.5.3).32 The effect 
of covariates on postoperative LOS was performed using 
Cox regression. ePOMS values were included as a time- 
dependent covariate calculated per day, and all other 
variables were assumed to exert effect over the entire 
postoperative period. Univariable analysis was performed 
for all variables, those with a p<0.1 on initial regression 
were carried forward for multivariable modelling. At this 
stage, statistical significance was taken as p<0.05. All anal-
yses were conducted in both complete case and multiply 
imputed data sets.
Handling of missing data
Daily entries in the EHR for calculating ePOMS (such as 
blood results, observations and administered drugs) were 
assumed to be accurate (eg, if no troponin test was ordered, 
a value was not imputed). Anaesthetic chart data (obser-
vations, measurements of gas tension) were also taken 
to be accurate due to automated data capture. Baseline 
patient variables (such as ASA Score) were imputed using 
multiple imputation with chained equations.33 This was 
performed using the R packages ‘mice’34 and ‘naniar’.35 
A full list of R packages used is available in the online 
supplementary material. A multilevel imputation model, 
clustered by individual, was used to allow imputation of 
baseline data alongside longitudinal ePOMSs.36 Visu-
alisation of missing data patterns are shown in online 
supplementary figure S3. Four variables had missing data; 
baseline creatinine (missing in 46%–8.7%), cognitive 
status (36%–6.8%), ASA Score (87%–16.1%) and mRS 
(192%–36.2%). All four were missing in only two cases. 
Forty imputed data sets were generated. Comparison of 
imputed and observed values can be seen graphically in 
online supplementary figure S4. All results presented in 
the results reflect pooled analyses across all imputed data 
sets, corresponding complete case analyses are in the 
online supplementary tables S2,S3.
resuLts
Cohort characteristics
These are summarised in table 2, dichotomised by referral 
source. Direct admissions were younger (median age 74 vs 
77, p=0.010), and had fewer patients with a favourable 
Motor Score on admission (79.5% vs 93.5%, p=0.001). 
Time to surgery after admission to the tertiary centre was 
not significantly different but this did not account for 
any additional wait in referring hospitals (median=10.6 
(4.7–28.4) hours). Reoperation for recurrence was asso-
ciated with significantly longer time to discharge (HR 
0.38 p<0.0001).
Operative exposures
Two hundred and thirty- five (44.2%) individuals received 
a volatile anaesthetic. Two hundred and forty (45.2%) 
had a recorded entry of an intravenous anaesthetic. 
The majority of remaining cases likely received intrave-
nous anaesthetic (due to the frequent presence of other 
anaesthetic drugs such as neuromuscular blockers on 
their drug chart) but could include a minority of cases 
performed under local anaesthetic.
Median duration of surgery was 96 min (IQR: 78.0–
103.5) with a maximum length of 318 min. Median time 
with a MAP <80 mm Hg was 45 min (IQR: 25–69). Median 
time outside of the optimal CO2 range was 8 min (IQR: 
4–15). Median opioid dose in fentanyl equivalents was 
100 µg (IQR: 50–150).
Inpatient morbidity
Thirteen individuals (2.4%) died during admission. Forty- 
nine (9.2%) patients were re- operated for their cSDH, 
twenty- eight during their index admission. Fifty- three 
(10%) individuals exhibited some degree of postoper-
ative troponin rise, with twenty- four (4.5%) developing 
acute kidney injury. Three hundred and forty- six (65.2%) 
patients had a degree of preoperative deterioration 
between admission and surgery as determined by an 
increase in their ePOMS between these time points.
The prevalence of each complication subtype shown 
by postoperative day is demonstrated in figures 1 and 2. 
There was an obvious restoration in focal neurology over 
the first 2 postoperative days (figure 1), although no such 
trend was apparent in those needing 1:1 observation. 
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Table 2 Baseline characteristics of retrospective cohort of operated chronic subdural haematoma (n=530)
All (n=530) Referred (n=491) Local (n=39) P value
Variable Median (IQR)
Age, years 77 (69–84) 77 (70–84) 74 (62–79) 0.010*
Creatinine, μmol/L 73 (61–89) 73 (61–89) 76 (64–100) 0.350
Time to surgery (within centre), 
hours
20.1 (9.5–40.3) 20.1 (9.8–42.7) 19.7 (5.2–35.9) 0.363
  n (%)
Male 376 (70.8) 349 (70.9) 27 (69.2) 0.855
ASA ≥3 271 (61.0)% 250 (61.2) 20 (57.1) 0.718
Cognitively impaired 270 (54.5)% 254 (54.9) 16 (48.5) 0.485
Admission GCS 15 342 (64.4) 317 (64.5) 25 (64.1) 1
Admission Motor Score 6 490 (92.3) 459 (93.5) 31 (79.5) 0.001*
mRS ≥2 105 (31.0)% 104 (21.2) 1 (20.0) 1
Anticoagulants/antiplatelets 232 (43.9) 211 (43.0) 21 (53.8) 0.241
CVS disease 238 (45.0) 225 (45.8) 13 (33.3) 0.136
Heart failure 101 (19.0) 90 (18.3) 11 (28.2) 0.139
Airways disease 75 (14.1) 66 (13.4) 9 (23.1) 0.099
‘Referred’ indicates cases referred from a regional hospital for surgery. ‘Local’ indicates a case admitted directly to the tertiary centre. Motor 
Score refers to score on the motor (movement) component of the Glasgow Coma Scale.
ASA of 3 or more indicates presence of significant systemic comorbidity, Modified Rankin Scale of 2 or more indicates a level of disability 
that impedes normal activity. % Indicates that value is calculated only on those with recorded values. P value calculated for Mann- Whitney U 
(continuous data) or Fisher’s exact test (categorical).
*Indicates significant at 5% level.
ASA, American Society of Anesthesiologists Score; CVS, cardiovascular; GCS, Glasgow Coma Scale; mRS, Modified Rankin Score.
Figure 1 Proportion of inpatients with specific neurological complications, extracted from an electronic health record, after 
surgery for chronic subdural haematoma, by postoperative day (n=530). GCS, Glasgow Coma Scale.
Plots of incident complications in neurological, cardio-
vascular, respiratory, gastrointestinal, pain and infectious 
complications by day are shown in online supplementary 
figures S5 and S6. Cases of new, worsening neurology 
after surgery were rare (online supplementary figure S5), 
a pattern which differed from that of non- neurological 
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Figure 2 Proportion of inpatients with organ specific complications (as defined by the Electronic Postoperative Morbidity 
Score), after surgery for chronic subdural haematoma, by postoperative day (n=530). GI, gastrointestinal.
complications (especially cardiovascular and respiratory) 
where new cases occurred throughout measured inpa-
tient stay.
The apparently high prevalence of respiratory ‘compli-
cations’ on day of surgery and postoperative day 1 is 
likely spurious, reflecting the routine use of supple-
mental oxygen to counteract postanaesthetic effects. The 
prevalence of infective complications appeared highest 
between days 3 and 10 (figure 2). By day 3, 280 individ-
uals (58% of 484 remaining inpatients) had at least one 
complication, a comparable rate to day 7—138 of 242 
remaining inpatients (57%).
Length of stay
Overall median LOS in the tertiary centre was 6.7 (IQR: 
4.2–10.6) days. For directly admitted patients, this was 8.9 
(IQR: 5.2–16.3) days versus 6.5 (IQR: 4.1–10.1) days for 
those referred from elsewhere. Postoperative LOS was 
4.9 (3.0–8.8) days in referred patients, compared with 
7.9 (3.4–15.5) days in local patients. Postoperative time 
to discharge, dichotomised by referral source is shown in 
figure 3.
Association of intraoperative events and complications on 
postoperative LOs.
From examined operative variables, only operative 
time demonstrated a significant association (HR: 0.97 
(0.95–0.99)) on univariable analysis. Postoperative 
complications were associated with prolonged postop-
erative stay (HR: 0.57 (0.52–0.63)) when included as a 
time- dependent covariate. Baseline variables including 
age, sex, ASA Score, mRS, medical state and comorbid-
ities were associated with longer time to postoperative 
discharge (table 3), while a favourable GCS and being 
from a referred hospital was associated with a more rapid 
discharge from the tertiary centre.
Multivariable analysis
Eighteen of these variables were taken forward to multi-
variable modelling (table 4). This was done to maximise 
control of confounding. Postoperative complications 
(HR: 0.61 (0.55–0.68)), cognitive concerns (HR: 0.71 
(0.58–0.87)) and anticoagulation (HR: 0.45 (0.37–0.54)) 
were all associated with longer time to discharge. Admis-
sion GCS (HR: 1.03 (0.97–1.08)) and referral source 
(HR: 1.46 (0.98–2.17)) were not significant in the final 
model. On complete case analysis, the pattern was similar 
except for an identified association with more rapid 
discharge with higher admission complication (ePOMS) 
scores (HR complete case 1.14 (1.04–1.26) vs HR MI: 1.06 
(0.99–1.12)) (online supplementary table S3).
Based on these results, two sensitivity analyses were 
performed to attempt to understand the apparent lack 
of association between admission GCS and postopera-
tive stay. First, total GCS was replaced with an indicator 
for motor score (6 or not) (online supplementary table 
S4), and second, a potential mediating effect of post-
operative complications was examined by removing this 
covariate (online supplementary table S5). In the first 
analysis, motor score was not associated with postopera-
tive time to discharge. In the second analysis, no signifi-
cant association with GCS was revealed in the subsequent 
model, although significant associations with admission 
ASA Score, renal function and age did become apparent 
(online supplementary table S5).
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Figure 3 Kaplan- Meier curves for postoperative time to discharge, dichotomised by referral source, in a retrospective cohort 
of operated chronic subdural haematoma (n=530). CUH, patients admitted directly to the neurosurgical centre at Cambridge 
University Hospitals NHS Foundation Trust; Non- CUH, patients referred from other hospitals in the region. Shaded areas=95% 
CI, dashed lines indicate median postoperative length of stay by group.
DIsCussIOn
To our knowledge, this is the first study in cSDH to use 
routinely collected EHR data to define postoperative 
morbidity and clinical interventions, such as anaesthetic 
events, while exploring their impact on LOS.
Principal findings
We highlight a significant degree of postoperative 
morbidity in surgically treated cSDH. Despite comparable 
cSDH recurrence rates of 9.2% (9% in a UK wide audit of 
practice11), in- patient morbidity captured by the ePOMS 
demonstrated a prevalence of medical complications of 
over 50% in the 2 weeks after surgery. Overall, 13% of 
patients demonstrated a rise in serum troponin or an 
episode of renal injury. Postoperative morbidity was signifi-
cantly associated with longer tertiary centre LOS, raising 
the question of whether efforts to pre- empt or aggres-
sively manage such morbidity could afford more efficient 
healthcare delivery and improved patient outcome. The 
total in- hospital burden of morbidity is likely higher than 
our estimate, as the single- centre nature of our study did 
not include complications occurring in a patient’s refer-
ring hospital. Our study design also prevents us exam-
ining the associations with total inpatient stay due to 
likely significant unmeasured events, including bed and 
transport availability. This data structure also precludes 
an assessment of mid- term mortality as records are not 
linked. Regardless, the presented findings are likely to be 
highly relevant to practice within tertiary neurosurgical 
centres.
baseline factors and confounding
Cognitive function on admission, admission anticoagula-
tion and postoperative complications were all associated 
with longer time to discharge. Importantly, admission GCS 
was not associated with postoperative stay. One interpre-
tation could be that any impact of preoperative neurology 
on postoperative course may be mediated through the 
included postoperative complication term (eg, low GCS is 
associated with LOS through a predisposition to compli-
cations, such as pneumonia). This explanation was not 
supported by a sensitivity analysis (online supplementary 
table S5). A larger question is to consider which measure 
of neurological morbidity is best for prognostication in 
this patient cohort, both in terms of underlying patho-
physiology and data coding. For instance, an individual 
with a hemiparesis arising from a non- dominant hemi-
sphere lesion would likely be recorded as possessing a 
motor score of 6 and a GCS of 15, thus weakening any 
observed association. Unpicking these issues and the 
co- linearity, inherent within these overlapping variables is 
difficult and should be explored in larger data sets.
We have attempted to control for many important 
variables identified in previous work in traumatic neuro-
surgical patients.37 . The shift in HR for referral source 
between univariable and multivariable modelling suggests 
that at least some of its observed association with time to 
discharge reflects confounding or mediation by included 
variables. This perhaps reflects differences in patient 
cohorts (such as admission motor score or age—table 2), 
or management between local and referred patients. 
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Table 3 Results from univariable Cox regression of effects of specific variables on postoperative length of stay in a cohort of 
patients undergoing surgery for cSDH (n=530) pooled across m=40 imputed data sets
HR 95% CI P value
Demographics
Age (per year increase) 0.99 0.99 to 0.99 0.042*
Sex (male vs female) 1.20 0.99 to 1.45 0.053*
Referred patient 2.20 1.54 to 3.13 <0.001*
  ASA 2 (all vs ASA 1) 0.50 0.31 to 0.82 0.006*
  ASA 3 0.34 0.21 to 0.55 <0.001*
  ASA 4 0.26 0.15 to 0.45 <0.001*
  ASA 5 0.22 0.07 to 0.68 0.009*
mRS 1 (all vs mRS 0) 0.86 0.67 to 1.11 0.249
  mRS 2 0.83 0.58 to 1.18 0.299
  mRS 3 0.73 0.47 to 1.11 0.142
  mRS 4 0.68 0.46 to 0.98 0.040*
Admission status
  GCS 15 on admission (vs any other) 1.11 1.06 to 1.16 <0.001*
  Admission ePOMS (per 1 domain increase) 0.91 0.87 to 0.97 0.002*
  Cognitive impairment (yes/no) 0.57 0.48 to 0.69 <0.001*
Comorbidities
  Airways disease 0.75 0.58 to 0.96 0.020*
  CVS disease 0.83 0.70 to 0.99 0.040*
  Heart failure 0.70 0.56 to 0.87 0.001*
  Anticoagulated on admission 0.42 0.35 to 0.50 <0.001*
  Creatinine (per 20 µmol/L increase) 0.96 0.92 to 0.99 0.022*
Day of surgery
  Preoperative deterioration (yes/no) 1.07 0.89 to 1.28 0.488
  Length of wait (per hour) 0.96 0.92 to 1.01 0.142
  Time MAP <80 mm Hg (per 10 min increase) 0.99 0.97 to 1.02 0.720
  Time ETCO2 not 3–5 kPa (per 10 min increase) 0.98 0.92 to 1.05 0.616
  Fentanyl dose (per 25 µg increase) 1.01 0.99 to 1.04 0.330
  Volatile maintenance 0.99 0.84 to 1.18 0.964
  Operative time (per 10 min increase) 0.97 0.95 to 0.99 0.004*
Postoperative
  Complications (per 1 domain increase in ePOMS) 0.57 0.52 to 0.63 <0.001*
HRs >1 indicate a more rapid time to postoperative discharge.
*Indicate statistical significance at p<0.1, chosen threshold for inclusion in subsequent multivariable modelling. Postoperative complications 
included as a time- dependent covariate (by day).
ASA, American Society of Anesthesiologists Score; CVS, cardiovascular; ePOMS, Electronic Postoperative Morbidity Score; ETCO2, end- tidal 
carbon dioxide measurement; GCS, Glasgow Coma Scale; MAP, mean arterial pressure; mRS, Modified Rankin Scale.
These findings require further evaluation in future 
studies and distinct cohorts.
Comparison to other literature
Although not widely examined, studies that have exam-
ined medical complications in cSDH have suggested that 
they may be a significant burden. A 2014 cross- sectional 
survey of UK neurosurgical centres demonstrated that 
approximately 110 (14%) of 787 surgically treated cSDH 
suffered a complication. In this survey, morbidity was 
defined as, ‘…any adverse event occurring during inpa-
tient stay…’,38 with a predefined audit target of <10%. In 
our study, ePOMS defined morbidity peaked at 65.2%. 
This higher prevalence likely reflects the sensitivity of the 
scoring system, enabling the measurement of ‘lower- level’ 
morbidity not captured in previous studies. However, the 
consistent association of such ePOMS- defined morbidity 
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Table 4 Multivariable Cox regression model for postoperative time to discharge in a cohort of patients undergoing surgery for 
chronic subdural haematoma (n=531), pooled across m=40 imputed data sets
HR 95% CI P value
Age (per year increase) 0.99 0.99 to 1.00 0.114
Sex (male vs female) 1.09 0.90 to 1.33 0.351
GCS 15 (vs any- other value) 1.03 0.97 to 1.08 0.377
Referred patient 1.46 0.98 to 2.17 0.063
ASA (per 1 level increase) 0.90 0.77 to 1.06 0.217
Admission complications 1.06 0.99 to 1.12 0.093
Airways disease (yes/no) 1.03 0.79 to 1.34 0.819
CVS disease (yes/no) 0.96 0.77 to 1.18 0.676
Anticoagulated on admission (yes/no) 0.45 0.37 to 0.54 <0.001*
Heart failure (yes/no) 1.02 0.77 to 1.33 0.908
mRS (per 1 level increase) 0.99 0.91 to 1.09 0.885
Baseline creatinine (per 20 µmol/L increase) 0.98 0.94 to 1.01 0.242
Cognitive concern (yes/no) 0.71 0.58 to 0.87 <0.001*
Operative time (per 10 min increase) 0.99 0.91 to 1.01 0.357
Postoperative complications (per 1 domain increase in 
ePOMS)
0.61 0.55 to 0.68 <0.001*
HRs >1 indicate association with a more rapid time to discharge.
*Indicate statistical significance at the 5% level. Postoperative complications included as a time- dependent covariate (by day).
ASA, American Society of Anesthesiologists score; CVS, cardiovascular; ePOMS, Electronic Postoperative Morbidity Score; GCS, Glasgow 
Coma Scale; mRS, Modified Rankin Scale.
with LOS indicates that it is likely to be of clinical rele-
vance. As EHR and standardised data collection become 
more widespread, the utilisation of phenotyping tech-
niques, such as the ePOMS, will become increasingly 
important but, in the short term, create a degree of diffi-
culty in allowing direct comparisons to the previously 
published literature.
utility of ehr in exploring perioperative care
The evidence from our study is that interrogation of the 
EHR data may be a valuable addition to the improve-
ment process, allowing the extraction and analysis of 
complex events and the use of computable phenotypes. 
This approach enables the evaluation of previously 
unmeasured clinical interactions on patient outcomes at 
different stages of the patient journey. The importance 
of integrated care at a system level is widely recognised 
in the care of traumatic brain injury. Here, interven-
tions and further research can be prioritised based on an 
understanding of the drivers of outcome in each phase 
of care.39 The nature of the cSDH referral pathway and 
the inherent complexity of the patient cohort means 
simple interventions to improve outcome are unlikely to 
be successful and a similar ‘system- wide’ approach may be 
required. Studies, such as ours which examine hitherto 
unexplored events, will be essential for defining both the 
scope of the problem and areas for improvement.
In this study, we have evaluated the impact of poten-
tially significant elements of intraoperative care for the 
first time in a cohort of patients with cSDH. Significant 
associations with LOS were not found. We defined covari-
ates based on time outside optimal ranges, deviation 
from which is associated with adverse outcome in other 
surgical specialities,15 or recommended as physiologi-
cally appropriate in more severe head injury.30 40 Periods 
of time (10 min or more) spent at a MAP of <80 mm Hg 
are associated with end- organ complications in non- 
cardiac surgery.15 In the same setting, a ‘dosing effect’ is 
suggested, with shorter periods of time under lower MAP 
values associated with complications. Overall, 80 mm Hg 
was chosen for this project due to its recommendation 
in other settings of neurosurgical practice40 but perhaps 
total time below this threshold, without considering a 
dosing effect may explain the lack of any observed asso-
ciation. Similarly, it may be that MAP targets should be 
individualised based on patient characteristics such as 
comorbidities, and exploring such interactions represent 
a potential area of future research.
Limitations of ehr data
Utilising EHR- derived data has limitations, the majority 
of which are grounded in the availability of readily 
extractable data encapsulating key clinical characteris-
tics such as radiological diagnoses or the specific events 
occurring during an operative procedure. The absence 
of information such as comorbidities required the use of 
novel phenotyping methods based on prescription medi-
cines.31 Although this methodology has been used in a 
large Australian database, the score has not previously, to 
our knowledge, been used in the surgical setting. Thus, 
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novel elements of our methodology including drug- 
inferred comorbidities and the ePOMS require robust 
external validation in a distinct data set despite apparent 
face validity. In larger cohorts, exploration of whether a 
weighted score (where different domains exert differing 
effects on LOS) could be explored. The need for such 
methods may vary by cohort and type of admission (eg, 
emergency vs elective). Hospital coding for SDH does 
not confidently delineate acute from chronic SDH,41 and 
operative codes do not encapsulate the specific technique 
used. In order to maintain anonymity of individual cases, 
we were not able to explore this by extracting free- text 
radiographic or operative details. Such analysis cannot be 
readily applied in a scaleable manner to allow automated 
calculation from aggregate data. Limitations on case defi-
nition in this study were mitigated through linkage with 
the centre’s neurosurgical referral database, where cases 
are contemporaneously coded by a neurosurgical clini-
cian, including a distinction between acute and cSDH. 
In addition, cases identified through coding data were 
refined by excluding those with associated major trau-
matic injuries to minimise the inclusion of cases of acute 
SDH. Despite these measures, it is possible that some 
cases were incorrectly included.
Conclusion
This study provides the first comprehensive evaluation of 
inpatient care for surgically treated cSDH using routinely 
collected data from an integrated EHR. Perioperative 
morbidity was common and associated with increased 
postoperative LOS. Preoperative anticoagulation, admis-
sion GCS, cognitive dysfunction and referral source 
were also associated with postoperative LOS. This study 
identifies key areas to explore in quality improvement 
initiatives, while providing a methodological framework 
relevant to neurosurgery, as well as other surgical and 
inpatient specialities.
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